Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Arm band zaps away teen migraines without drugs

NCT ID NCT05443659

Symptom relief Sponsor: Theranica Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at how well a device called Nerivio works for treating migraines in teenagers aged 12 to 18. The device is worn on the upper arm and uses mild electrical pulses to trigger the body's natural pain relief system. Researchers analyzed data from over 1,600 teens who used the device at home, checking if pain eased within 2 hours without needing extra medication.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Nerivio device (remote electrical neuromodulation)
What this could lead to
If successful, this could confirm that a non-drug device worn on the arm safely eases migraine pain in teens, offering a drug-free option.
What could go wrong
This is a real-world analysis, not a controlled trial, so results may be less reliable. The device may not work for all teens, and some may still need medication.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

1,629 people

The number who actually took part.

Started

Jan 2021

Finished

Aug 2022

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adolescence (age 12-18) who suffers from migraine who are using the Nerivio device for acute treatment of migraine

Ages

12 to 18 years

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. \- Age between 12-18 years 2. \- REN user across the United States who created Nerivio account on January 1st, 2021 or later. 3. \- Had at least two evaluable treatments with the Nerivio device Exclusion Criteria: (1) - Treatments shorter than 20 minutes

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Migraine in adolescence are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

migraine disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Migraine in adolescence

Contacts and locations

Locations

  • Theranica Bio-Electronics Ltd

    Netanya, 4250438, Israel

  • Theranica USA Inc

    Bridgewater, New Jersey, 08807, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.